Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Date fruit dataset for intelligent harvesting.

Altaheri H, Alsulaiman M, Muhammad G, Amin SU, Bencherif M, Mekhtiche M.

Data Brief. 2019 Sep 18;26:104514. doi: 10.1016/j.dib.2019.104514. eCollection 2019 Oct.

2.

A Cross-Layer, Anomaly-Based IDS for WSN and MANET.

Amouri A, Morgera SD, Bencherif MA, Manthena R.

Sensors (Basel). 2018 Feb 22;18(2). pii: E651. doi: 10.3390/s18020651.

3.

TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors.

Wall TR, Henderson BJ, Voren G, Wageman CR, Deshpande P, Cohen BN, Grady SR, Marks MJ, Yohannes D, Kenny PJ, Bencherif M, Lester HA.

Front Pharmacol. 2017 Sep 26;8:641. doi: 10.3389/fphar.2017.00641. eCollection 2017.

4.

An Investigation of Multidimensional Voice Program Parameters in Three Different Databases for Voice Pathology Detection and Classification.

Al-Nasheri A, Muhammad G, Alsulaiman M, Ali Z, Mesallam TA, Farahat M, Malki KH, Bencherif MA.

J Voice. 2017 Jan;31(1):113.e9-113.e18. doi: 10.1016/j.jvoice.2016.03.019. Epub 2016 Apr 19.

PMID:
27105857
5.

The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists.

Kucinski A, Wersinger S, Stachowiak EK, Becker C, Lippiello P, Bencherif M, Stachowiak MK.

Behav Pharmacol. 2015 Feb;26(1-2):217-26. doi: 10.1097/FBP.0000000000000122.

PMID:
25485645
6.

[Cystic adenoid carcinoma of the eyelids: report of a case].

Elouarradi H, Bencherif MZ.

Pan Afr Med J. 2014 Mar 28;17:239. doi: 10.11604/pamj.2014.17.239.3488. eCollection 2014. French. No abstract available.

7.

[A neglected conjunctival epidermoid carcinoma: a case report].

Elouarradi H, Bencherif MZ.

Pan Afr Med J. 2014 Mar 24;17:226. doi: 10.11604/pamj.2014.17.226.3561. eCollection 2014. French. No abstract available.

8.

Understanding the role α7 nicotinic receptors play in dopamine efflux in nucleus accumbens.

Maex R, Grinevich VP, Grinevich V, Budygin E, Bencherif M, Gutkin B.

ACS Chem Neurosci. 2014 Oct 15;5(10):1032-40. doi: 10.1021/cn500126t. Epub 2014 Aug 29.

9.

Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs).

Strachan JP, Kombo DC, Mazurov A, Heemstra R, Bhatti BS, Akireddy R, Murthy S, Miao L, Jett JE, Speake J, Bencherif M.

Eur J Med Chem. 2014 Oct 30;86:60-74. doi: 10.1016/j.ejmech.2014.08.019. Epub 2014 Aug 7.

PMID:
25147147
10.

[Colobomatous cyst of the orbit].

Elouarradi H, Bencherif MZ.

Pan Afr Med J. 2014 Mar 5;17:159. doi: 10.11604/pamj.2014.17.159.3462. eCollection 2014. French. No abstract available.

11.

Alpha7 neuronal nicotinic receptor: a pluripotent target for diseases of the central nervous system.

Bencherif M, Narla ST, Stachowiak MS.

CNS Neurol Disord Drug Targets. 2014;13(5):836-45. Review.

PMID:
25012615
12.

[Orbital hydatid cyst: non exceptional cause if exophthalmia in Morocco].

Handor H, Bencherif MZ.

Pan Afr Med J. 2013 Aug 23;15:147. doi: 10.11604/pamj.2013.15.147.3167. eCollection 2013. French. No abstract available.

13.

[Congenital ptosis: experience of a tertiary Moroccan center and latest development].

Handor H, Hafidi Z, Bencherif M, Amrani Y, belmokhtar A, Laghmari M, Daoudi R.

Pan Afr Med J. 2014 Oct 15;19:150. doi: 10.11604/pamj.2014.19.150.3072. eCollection 2014. French. No abstract available.

14.

Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypes.

Kombo DC, Bencherif M.

J Chem Inf Model. 2013 Dec 23;53(12):3212-22. doi: 10.1021/ci400493a. Epub 2013 Dec 11.

PMID:
24328365
15.

Activation of developmental nuclear fibroblast growth factor receptor 1 signaling and neurogenesis in adult brain by α7 nicotinic receptor agonist.

Narla ST, Klejbor I, Birkaya B, Lee YW, Morys J, Stachowiak EK, Prokop D, Bencherif M, Stachowiak MK.

Stem Cells Transl Med. 2013 Oct;2(10):776-88. doi: 10.5966/sctm.2012-0103. Epub 2013 Sep 6.

16.

Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modes.

Kombo DC, Mazurov AA, Strachan JP, Bencherif M.

Bioorg Med Chem Lett. 2013 Sep 15;23(18):5105-13. doi: 10.1016/j.bmcl.2013.07.028. Epub 2013 Jul 23.

PMID:
23937977
17.

α7 nicotinic receptor agonist reactivates neurogenesis in adult brain.

Narla S, Klejbor I, Birkaya B, Lee YW, Morys J, Stachowiak EK, Terranova C, Bencherif M, Stachowiak MK.

Biochem Pharmacol. 2013 Oct 15;86(8):1099-104. doi: 10.1016/j.bcp.2013.07.028. Epub 2013 Aug 9. Review.

PMID:
23933384
18.

Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease.

Zhang D, Mallela A, Sohn D, Carroll FI, Bencherif M, Letchworth S, Quik M.

J Pharmacol Exp Ther. 2013 Oct;347(1):225-34. doi: 10.1124/jpet.113.207639. Epub 2013 Jul 31.

19.

QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at the α4β2 and α3β4 nicotinic acetylcholine receptors (nAChRs).

Kombo DC, Grinevich VP, Hauser TA, Sidach S, Bencherif M.

Bioorg Med Chem Lett. 2013 Sep 1;23(17):4842-7. doi: 10.1016/j.bmcl.2013.06.094. Epub 2013 Jul 6.

PMID:
23886687
20.

Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease.

Kucinski A, Wersinger S, Stachowiak EK, Corso TD, Parry MJ, Zhang J, Jordan K, Letchworth S, Bencherif M, Stachowiak MK.

Pharmacol Biochem Behav. 2013 Oct;111:1-10. doi: 10.1016/j.pbb.2013.07.005. Epub 2013 Jul 16.

PMID:
23872135
21.

Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model.

Stachowiak MK, Kucinski A, Curl R, Syposs C, Yang Y, Narla S, Terranova C, Prokop D, Klejbor I, Bencherif M, Birkaya B, Corso T, Parikh A, Tzanakakis ES, Wersinger S, Stachowiak EK.

Schizophr Res. 2013 Feb;143(2-3):367-76. doi: 10.1016/j.schres.2012.11.004. Epub 2012 Dec 8. Review.

PMID:
23231877
22.

Slice XVIvo™: a novel electrophysiology system with the capability for 16 independent brain slice recordings.

Graef JD, Wei H, Lippiello PM, Bencherif M, Fedorov N.

J Neurosci Methods. 2013 Jan 30;212(2):228-33. doi: 10.1016/j.jneumeth.2012.10.009. Epub 2012 Oct 23.

PMID:
23099344
23.

Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptors.

Zhang J, Xiao YD, Jordan KG, Hammond PS, Van Dyke KM, Mazurov AA, Speake JD, Lippiello PM, James JW, Letchworth SR, Bencherif M, Hauser TA.

Eur J Pharm Sci. 2012 Dec 18;47(5):813-23. doi: 10.1016/j.ejps.2012.09.014. Epub 2012 Oct 2.

PMID:
23036283
24.

Validation of a high-throughput, automated electrophysiology platform for the screening of nicotinic agonists and antagonists.

Graef JD, Benson LC, Sidach SS, Wei H, Lippiello PM, Bencherif M, Fedorov NB.

J Biomol Screen. 2013 Jan;18(1):116-27. doi: 10.1177/1087057112457414. Epub 2012 Sep 6.

PMID:
22960782
25.

A method for bidirectional solution exchange--"liquid bullet" applications of acetylcholine to α7 nicotinic receptors.

Fedorov N, Benson L, Graef JD, Hyman J, Sollenberger J, Pettersson F, Lippiello PM, Bencherif M.

J Neurosci Methods. 2012 Apr 30;206(1):23-33. doi: 10.1016/j.jneumeth.2012.02.005. Epub 2012 Feb 11.

PMID:
22342972
26.

Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia.

Bencherif M, Stachowiak MK, Kucinski AJ, Lippiello PM.

Med Hypotheses. 2012 May;78(5):594-600. doi: 10.1016/j.mehy.2012.01.035. Epub 2012 Feb 13.

PMID:
22336089
27.

α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.

Kucinski A, Syposs C, Wersinger S, Bencherif M, Stachowiak MK, Stachowiak EK.

Schizophr Res. 2012 Apr;136(1-3):82-7. doi: 10.1016/j.schres.2012.01.005. Epub 2012 Jan 30.

PMID:
22285656
28.

Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor.

Lummis SC, Thompson AJ, Bencherif M, Lester HA.

J Pharmacol Exp Ther. 2011 Oct;339(1):125-31. doi: 10.1124/jpet.111.185306. Epub 2011 Jul 20.

29.

Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophrenia.

Kucinski AJ, Stachowiak MK, Wersinger SR, Lippiello PM, Bencherif M.

Curr Pharm Biotechnol. 2011 Mar 1;12(3):437-48. Review.

PMID:
21133847
30.

Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.

Bencherif M, Lippiello PM, Lucas R, Marrero MB.

Cell Mol Life Sci. 2011 Mar;68(6):931-49. doi: 10.1007/s00018-010-0525-1. Epub 2010 Oct 15. Review.

31.

Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview.

Marrero MB, Bencherif M, Lippiello PM, Lucas R.

Pharm Res. 2011 Feb;28(2):413-6. doi: 10.1007/s11095-010-0283-7. Epub 2010 Sep 22. Review.

PMID:
20859658
32.

Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors.

Grady SR, Drenan RM, Breining SR, Yohannes D, Wageman CR, Fedorov NB, McKinney S, Whiteaker P, Bencherif M, Lester HA, Marks MJ.

Neuropharmacology. 2010 Jun;58(7):1054-66. doi: 10.1016/j.neuropharm.2010.01.013. Epub 2010 Jan 28.

33.

Alpha7 neuronal nicotinic receptors: the missing link to understanding Alzheimer's etiopathology?

Bencherif M, Lippiello PM.

Med Hypotheses. 2010 Feb;74(2):281-5. doi: 10.1016/j.mehy.2009.09.011. Epub 2009 Oct 1.

PMID:
19800174
34.

An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes.

Marrero MB, Lucas R, Salet C, Hauser TA, Mazurov A, Lippiello PM, Bencherif M.

J Pharmacol Exp Ther. 2010 Jan;332(1):173-80. doi: 10.1124/jpet.109.154633. Epub 2009 Sep 28.

PMID:
19786623
35.

Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the alpha6( *) subtype.

Breining SR, Bencherif M, Grady SR, Whiteaker P, Marks MJ, Wageman CR, Lester HA, Yohannes D.

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4359-63. doi: 10.1016/j.bmcl.2009.05.085. Epub 2009 May 27.

36.
37.

TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.

Hauser TA, Kucinski A, Jordan KG, Gatto GJ, Wersinger SR, Hesse RA, Stachowiak EK, Stachowiak MK, Papke RL, Lippiello PM, Bencherif M.

Biochem Pharmacol. 2009 Oct 1;78(7):803-12. doi: 10.1016/j.bcp.2009.05.030. Epub 2009 May 29.

38.

Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors.

Grinevich VP, Papke RL, Lippiello PM, Bencherif M.

Neuropharmacology. 2009 Aug;57(2):183-91. doi: 10.1016/j.neuropharm.2009.05.003. Epub 2009 May 28.

39.

Development and optimization of a high-throughput electrophysiology assay for neuronal alpha4beta2 nicotinic receptors.

Sidach SS, Fedorov NB, Lippiello PM, Bencherif M.

J Neurosci Methods. 2009 Aug 30;182(1):17-24. doi: 10.1016/j.jneumeth.2009.05.014. Epub 2009 May 27.

PMID:
19481112
40.

Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB.

Marrero MB, Bencherif M.

Brain Res. 2009 Feb 23;1256:1-7. doi: 10.1016/j.brainres.2008.11.053. Epub 2008 Nov 27.

PMID:
19063868
41.

TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity.

Lippiello PM, Beaver JS, Gatto GJ, James JW, Jordan KG, Traina VM, Xie J, Bencherif M.

CNS Neurosci Ther. 2008 Winter;14(4):266-77. doi: 10.1111/j.1755-5949.2008.00054.x. Review.

42.

Differential pharmacologies of mecamylamine enantiomers: positive allosteric modulation and noncompetitive inhibition.

Fedorov NB, Benson LC, Graef J, Lippiello PM, Bencherif M.

J Pharmacol Exp Ther. 2009 Feb;328(2):525-32. doi: 10.1124/jpet.108.146910. Epub 2008 Oct 28.

PMID:
18957576
43.

In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors.

Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM, Bupp S, Heintz N, McIntosh JM, Bencherif M, Marks MJ, Lester HA.

Neuron. 2008 Oct 9;60(1):123-36. doi: 10.1016/j.neuron.2008.09.009.

44.

Nicotinic receptors as targets for therapeutic discovery.

Lippiello P, Bencherif M, Hauser T, Jordan K, Letchworth S, Mazurov A.

Expert Opin Drug Discov. 2007 Sep;2(9):1185-203. doi: 10.1517/17460441.2.9.1185.

PMID:
23496128
45.

Ispronicline: a novel alpha4beta2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties.

Lippiello P, Letchworth SR, Gatto GJ, Traina VM, Bencherif M.

J Mol Neurosci. 2006;30(1-2):19-20.

PMID:
17192610
46.

Therapeutic potential of novel selective drugs targeting nicotinic acetylcholine receptors.

Bencherif M, Hauser TA, Jordan KG, Gatto GJ.

J Mol Neurosci. 2006;30(1-2):17-8.

PMID:
17192609
47.

(E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa.

Spoettl T, Paetzel C, Herfarth H, Bencherif M, Schoelmerich J, Greinwald R, Gatto GJ, Rogler G.

Int J Colorectal Dis. 2007 Mar;22(3):303-12. Epub 2006 May 20.

PMID:
16715250
48.

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance.

Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM.

Trends Pharmacol Sci. 2005 Jul;26(7):352-60. Review.

PMID:
15946748
49.

Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit.

Grinevich VP, Letchworth SR, Lindenberger KA, Menager J, Mary V, Sadieva KA, Buhlman LM, Bohme GA, Pradier L, Benavides J, Lukas RJ, Bencherif M.

J Pharmacol Exp Ther. 2005 Feb;312(2):619-26. Epub 2004 Sep 8.

PMID:
15356217
50.

TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.

Gatto GJ, Bohme GA, Caldwell WS, Letchworth SR, Traina VM, Obinu MC, Laville M, Reibaud M, Pradier L, Dunbar G, Bencherif M.

CNS Drug Rev. 2004 Summer;10(2):147-66. Review.

Supplemental Content

Loading ...
Support Center